Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-16

Clinical Trial Update: Caffeine for Motor Manifestations of Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating caffeine for motor manifestations of Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)

Snippet

Sponsor: Ron Postuma | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED